InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Martin George Kelly. Director active across 1 company, notably TriSalus Life Sciences, Inc.. Aggregated, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €44. Activity tracked since 28 August 2024. The latest transaction was filed on 28 August 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条